JY
FULC icon

Jeff Yass’s Fulcrum Therapeutics FULC Stock Holding History

Jeff Yass’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
175,400
+91,700
+110% +$558K ﹤0.01% 9331
2026
Q1 		$642K Sell
83,700
-27,100
-24% -$251K ﹤0.01% 9021
2025
Q4 		$1.25M Buy
110,800
+97,300
+721% +$990K ﹤0.01% 6652
2025
Q3 		$124K Sell
13,500
-12,200
-47% -$88.3K ﹤0.01% 11426
2025
Q2 		$177K Buy
+25,700
New +$137K ﹤0.01% 11339
2025
Q1 		– Sell
-19,900
Closed -$93.5K – 12809
2024
Q4 		$93.5K Sell
19,900
-151,300
-88% -$558K ﹤0.01% 11392
2024
Q3 		$611K Buy
+171,200
New +$1.27M ﹤0.01% 7982
2024
Q2 		– Sell
-19,500
Closed -$184K – 12411
2024
Q1 		$184K Sell
19,500
-43,000
-69% -$384K ﹤0.01% 10690
2023
Q4 		$422K Sell
62,500
-105,000
-63% -$466K ﹤0.01% 9074
2023
Q3 		$744K Buy
167,500
+116,600
+229% +$510K ﹤0.01% 7309
2023
Q2 		$168K Buy
50,900
+34,200
+205% +$100K ﹤0.01% 10454
2023
Q1 		$47.6K Sell
16,700
-2,400
-13% -$21.5K ﹤0.01% 11717
2022
Q4 		$139K Buy
19,100
+3,400
+22% +$22.2K ﹤0.01% 10599
2022
Q3 		$127K Sell
15,700
-13,700
-47% -$98.1K ﹤0.01% 11454
2022
Q2 		$144K Buy
29,400
+18,700
+175% +$183K ﹤0.01% 11077
2022
Q1 		$253K Sell
10,700
-5,800
-35% -$82.1K ﹤0.01% 10698
2021
Q4 		$292K Sell
16,500
-6,200
-27% -$123K ﹤0.01% 10560
2021
Q3 		$640K Buy
+22,700
New +$430K ﹤0.01% 8744

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's FULC Position: Q2 2026 in Review

Jeff Yass increased its Fulcrum Therapeutics (FULC) stake by 1,065% in Q2 2026, buying an estimated $6.57M and bringing the position to 1,180,946 shares worth $4.32M. The position accounts for ﹤0.01% of the portfolio, ranked #4908.

Jeff Yass first reported a position in FULC in Q3 2019 and has held it in 18 quarters since. The position peaked at $5.3M in Q1 2024. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Jeff Yass held 1,180,946 shares of Fulcrum Therapeutics worth $4.32M as of Q2 2026.
  • Jeff Yass bought 1,079,610 Fulcrum Therapeutics shares in Q2 2026, an estimated $6.57M.
  • Fulcrum Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4908 holding.
  • Jeff Yass first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 18 quarters since.
  • Jeff Yass's Fulcrum Therapeutics position peaked at $5.3M in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.